Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP558785.RAnuUeLHwBJY24rPYiNrAxAHEL6QqK-A3VozzpRVPjfrI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP558785.RAnuUeLHwBJY24rPYiNrAxAHEL6QqK-A3VozzpRVPjfrI130_assertion type Assertion NP558785.RAnuUeLHwBJY24rPYiNrAxAHEL6QqK-A3VozzpRVPjfrI130_head.
- NP558785.RAnuUeLHwBJY24rPYiNrAxAHEL6QqK-A3VozzpRVPjfrI130_assertion description "[Attenuation of MAP3K9 function in melanoma cells using siRNA led to increased cell viability after temozolomide treatment, suggesting that decreased MAP3K pathway activity can lead to chemoresistance in melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP558785.RAnuUeLHwBJY24rPYiNrAxAHEL6QqK-A3VozzpRVPjfrI130_provenance.
- NP558785.RAnuUeLHwBJY24rPYiNrAxAHEL6QqK-A3VozzpRVPjfrI130_assertion evidence source_evidence_literature NP558785.RAnuUeLHwBJY24rPYiNrAxAHEL6QqK-A3VozzpRVPjfrI130_provenance.
- NP558785.RAnuUeLHwBJY24rPYiNrAxAHEL6QqK-A3VozzpRVPjfrI130_assertion SIO_000772 22197930 NP558785.RAnuUeLHwBJY24rPYiNrAxAHEL6QqK-A3VozzpRVPjfrI130_provenance.
- NP558785.RAnuUeLHwBJY24rPYiNrAxAHEL6QqK-A3VozzpRVPjfrI130_assertion wasDerivedFrom befree-20150227 NP558785.RAnuUeLHwBJY24rPYiNrAxAHEL6QqK-A3VozzpRVPjfrI130_provenance.
- NP558785.RAnuUeLHwBJY24rPYiNrAxAHEL6QqK-A3VozzpRVPjfrI130_assertion wasGeneratedBy ECO_0000203 NP558785.RAnuUeLHwBJY24rPYiNrAxAHEL6QqK-A3VozzpRVPjfrI130_provenance.